Sentence examples for data from the development from inspiring English sources
To develop the TRIM-Diabetes, previous data from the development of the Diabetes TRIAD Measures were qualitatively re-examined and re-analyzed along with the newly collected information regarding inhaled and pump delivered insulin and thereby forming the basis for the TRIM-Diabetes/Device development project.
We extracted data from the development studies regarding the instruments' development and initial validation process.
We have examined the aforementioned predictions using transcriptome data from the development of Drosophila melanogaster and Arabidopsis thaliana.
We systematically evaluated our new tool in simulated datasets from several large-scale TCGA RNA-Seq projects, unbiased benchmark data from compcodeR package, and real RNA-Seq data from the development transcriptome of Drosophila.
The Australasian SAPS III equation was assessed in the entire population, but we only extracted data from the development cohort for comparison with SAPS III general equation data on calibration and SMR.
Thus, the estimated proportions of ARDS across the eight score ranges shown in Figure 4 are only based on the combined data from the development and prospective validation cohort (PARDS prior approximately = 0.5 in both cohorts), and should only be applied to patients from populations with similar prevalence of ARDS versus CPE.
The assessment was completed with the support of USAid and uses data compiled from the development of its poverty reduction strategy and its national vision.
Clinimetric data obtained from the development sample also provided estimates for comparison with estimates obtained in the independent validation sample.
As a starting point for the current study, only the data collected from the development of the BGNN classifier for the Anterior Myocardial Infarction was analysed.
The past two decades have been witness to an explosion of data stemming from the development and gradual maturation of 'omics' technologies and bioinformatics.
As a result, sponsors need to consider, plan, and in some cases launch CV outcome trials during the FDA review of their New Drug Application based on limited data from the clinical development program, thereby adding complexity and substantial expense to the drug's development.
